Babylon Health's administrators have confirmed that two of the company's divisions have been sold to US digital health business eMed, after an earlier bid to merge the gro
Babylon Health's efforts to raise financing to steady its business have been scuppered by the collapse of a proposed merger with digital therapeutics firm MindMaze, which
UK digital health company Babylon has hired Andrew Hine to take charge of its international expansion efforts, as it fights to retain its stock market listing in the US.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh